3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
85
Lung Neoplasms
63
Carcinoma, Non-Small-Cell Lung
50
Neoplasm Metastasis
48
Breast Neoplasms
48
Glioma
41
Glioblastoma
38
Pancreatic Neoplasms
35
Multiple Myeloma
35
Brain Neoplasms
34
Carcinoma, Renal Cell
32
Lymphoma, Large B-Cell, Diffuse
29
Melanoma
28
Urinary Bladder Neoplasms
27
Colorectal Neoplasms
27
Squamous Cell Carcinoma of Head and Neck
25
Ovarian Neoplasms
24
Triple Negative Breast Neoplasms
21
Oropharyngeal Neoplasms
21
Carcinoma, Hepatocellular
21
Lymphoma
20
Mouth Neoplasms
18
Lymphoma, Follicular
18
Sarcoma
17
Fallopian Tube Neoplasms
16
Carcinoma
16
Laryngeal Neoplasms
15
Carcinoma, Transitional Cell
15
Astrocytoma
15
Lymphoma, Mantle-Cell
14
Interventions
Gemcitabine
16
Mitomycin
10
Docetaxel
6
BCG Vaccine
6
erdafitinib
5
durvalumab
4
dodecyl maltoside
4
Cystoscopy
4
ALT-803
4
Radiotherapy
2
5-aminolevulinic acid hexyl ester
2
viscum album peptide
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
monalizumab
1
hydroxycamptothecinum
1
enfortumab vedotin
1
chondroitin sulfate, sodium hyaluronate drug combination
1
bicalutamide
1
Watchful Waiting
1
Urine Specimen Collection
1
Transurethral Resection of Bladder
1
Surveys and Questionnaires
1
Patient Discharge
1
Paclitaxel
1
Nonsteroidal Anti-Androgens
1
Mitozytrex
1
Maintenance
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Magnetic Resonance Spectroscopy
×
1 year
×
Clear all
NCT07000084
2026-06-02
GAIN-BCG
Alliance for Clinical Trials in Oncology
Phase 3
Recruiting
330 enrolled